Molecular mechanisms supporting a pathogenic role for human polyomavirus 6 small T antigen: Protein phosphatase 2A targeting and MAPK cascade activation

A taxonomy update for the family Polyomaviridae

(2016) Sébastien Calvignac-Spencer et al.   ARCHIVES OF VIROLOGY

Frequent detection of human polyomavirus 6 in keratoacanthomas

(2016) Jan Beckervordersandforth et al.   Diagnostic Pathology

Emerging differential roles of the pRb tumor suppressor in trichodysplasia spinulosa-associated polyomavirus and Merkel cell polyomavirus pathogeneses

(2016) Julie H. Wu et al.   JOURNAL OF CLINICAL VIROLOGY

Merkel cell polyomavirus in Merkel cell carcinogenesis: small T antigen-mediates c-Jun phosphorylation

(2016) Julie H. Wu et al.   VIRUS GENES

Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy

(2015) D. N. Cohen et al.   CLINICAL CANCER RESEARCH

Cutaneous Human Polyomavirus Small T Antigens and 4E-BP1 Targeting

(2015) Julie H. Wu et al.   INTERVIROLOGY

Mechanism and consequences of RAF kinase activation by small-molecule inhibitors

(2014) M Holderfield et al.   BRITISH JOURNAL OF CANCER

Spindle Cell Squamous Carcinoma During BRAF Inhibitor Therapy for Advanced Melanoma

(2014) Daniel N. Cohen et al.   JAMA Dermatology

Presence of Human Polyomavirus 6 in Mutation-Specific BRAF Inhibitor–Induced Epithelial Proliferations

(2014) David Schrama et al.   JAMA Dermatology

Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer

(2013) Parthasarathy Seshacharyulu et al.   CANCER LETTERS

Age-Specific Seroprevalences of Merkel Cell Polyomavirus, Human Polyomaviruses 6, 7, and 9, and Trichodysplasia Spinulosa-Associated Polyomavirus

(2013) Jérôme T. J. Nicol et al.   Clinical and Vaccine Immunology

Paradoxical oncogenesis—the long-term effects of BRAF inhibition in melanoma

(2013) Geoffrey T. Gibney et al.   Nature Reviews Clinical Oncology

Different Serologic Behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 Polyomaviruses Found on the Skin

(2013) Els van der Meijden et al.   PLoS One

Squamoproliferative Lesions Arising in the Setting of BRAF Inhibition

(2012) Nathan T. Harvey et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic study

(2012) Emily Y. Chu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

RASMutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

(2012) Fei Su et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genome analysis of the new human polyomaviruses

(2012) Marijke Van Ghelue et al.   REVIEWS IN MEDICAL VIROLOGY

PP2A targeting by viral proteins: A widespread biological strategy from DNA/RNA tumor viruses to HIV-1

(2011) Julien Guergnon et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator

(2011) Masahiro Shuda et al.   JOURNAL OF CLINICAL INVESTIGATION

Merkel Cell Polyomavirus and Two Previously Unknown Polyomaviruses Are Chronically Shed from Human Skin

(2010) Rachel M. Schowalter et al.   Cell Host & Microbe

SV40 small T antigen and PP2A phosphatase in cell transformation

(2008) Anna A. Sablina et al.   CANCER AND METASTASIS REVIEWS

Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival

(2007) Melissa R. Junttila et al.   FASEB JOURNAL